• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

An update on randomized clinical trials in localized and locoregional prostate cancer.

作者信息

Penson David F

机构信息

Urology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.

出版信息

Urol Oncol. 2005 Jul-Aug;23(4):280-8. doi: 10.1016/j.urolonc.2005.05.006.

DOI:10.1016/j.urolonc.2005.05.006
PMID:16018945
Abstract

It is important that treatment decisions be based upon scientific data, as opposed to anecdotal experience and expert opinion. The goal of this article is to provide an update on phase III clinical trials in localized and locoregional prostate cancer. Studies comparing surgery and observation for localized disease are reviewed, as are studies comparing various forms of radiotherapy. The effectiveness of certain neoadjuvant and adjuvant therapies is also addressed. Although there are numerous phase III studies ongoing in these areas, there are still large gaps in our understanding of the treatment of localized disease, and additional clinical trials are needed.

摘要

相似文献

1
An update on randomized clinical trials in localized and locoregional prostate cancer.
Urol Oncol. 2005 Jul-Aug;23(4):280-8. doi: 10.1016/j.urolonc.2005.05.006.
2
[Prostate cancer].
Gan To Kagaku Ryoho. 2007 Nov;34(11):1740-4.
3
Contemporary treatment of high-risk localized prostate cancer.当代高危局限性前列腺癌的治疗方法。
Expert Rev Anticancer Ther. 2010 Jul;10(7):1069-76. doi: 10.1586/era.10.36.
4
Adjuvant systemic therapy of prostate cancer.前列腺癌的辅助全身治疗。
Semin Oncol. 1995 Dec;22(6):633-40.
5
Prostate cancer: non-metastatic.前列腺癌:非转移性。
Clin Evid. 2002 Jun(7):812-23.
6
[Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].[前列腺癌根治术后局部晚期前列腺癌辅助治疗的利弊]
Aktuelle Urol. 2004 Sep;35(5):371-2. doi: 10.1055/s-2004-834362.
7
Adjuvant and neoadjuvant therapies in high risk localized prostate cancer.高危局限性前列腺癌的辅助治疗和新辅助治疗
J Exp Clin Cancer Res. 2006 Dec;25(4):469-73.
8
Adjuvant radiotherapy after radical prostatectomy: indications, results and side effects.前列腺癌根治术后辅助放疗:适应证、疗效及副作用
Urol Int. 2007;78(3):193-7. doi: 10.1159/000099336.
9
[Current methods of radical treatment for localized prostate cancer].[局限性前列腺癌的当前根治性治疗方法]
Vopr Onkol. 2008;54(1):108-12.
10
Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?剂量递增的外照射放疗与新辅助雄激素剥夺疗法及常规剂量外照射放疗用于临床局限性前列腺癌:两者我们都需要吗?
Strahlenther Onkol. 2007 Dec;183 Spec No 2:26-8. doi: 10.1007/s00066-007-2011-8.

引用本文的文献

1
External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study.高危前列腺癌的体外放射治疗与根治性前列腺切除术:RECOVER研究方案
BMC Cancer. 2025 Jan 27;25(1):149. doi: 10.1186/s12885-025-13511-7.
2
Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses.根治性前列腺切除术与放疗治疗局限性或局部进展性前列腺癌的韩国男性患者的癌症特异性死亡率:使用倾向评分和竞争风险回归分析的多中心研究。
Cancer Res Treat. 2018 Jan;50(1):129-137. doi: 10.4143/crt.2017.004. Epub 2017 Mar 8.
3
Comparative effectiveness of radical prostatectomy and curative radiotherapy in localized prostate cancer: long-term follow-up.
局限性前列腺癌根治性前列腺切除术与根治性放疗的疗效比较:长期随访
J Radiat Res. 2017 Jul 1;58(4):552-558. doi: 10.1093/jrr/rrw119.
4
Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.极高风险局限性前列腺癌:根治性放疗后的结局
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):254-62. doi: 10.1016/j.ijrobp.2015.10.056. Epub 2015 Oct 31.
5
Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths.癌症登记处可以提供基于证据的数据,以提高医疗质量并预防癌症死亡。
Ecancermedicalscience. 2014 Mar 28;8:413. doi: 10.3332/ecancer.2014.413. eCollection 2014.
6
Prostate cancer: should men with metastases undergo radical prostatectomy?前列腺癌:有转移的男性患者应接受前列腺根治切除术吗?
Nat Rev Urol. 2013 Sep;10(9):501-2. doi: 10.1038/nrurol.2013.154. Epub 2013 Jul 16.
7
Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy.接受根治性前列腺切除术与根治性放疗的患者在前列腺癌特异性生存率上的差异。
Can Urol Assoc J. 2013 May-Jun;7(5-6):E299-305. doi: 10.5489/cuaj.11294. Epub 2013 May 13.